{"disease":{"id":"superficial-palpable-unresectable-metastatic-solid-tumour","name":"superficial palpable unresectable metastatic solid tumour"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03593226","title":"Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Agalimmune Ltd.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}